替罗非班治疗颅内动脉瘤介入围手术期支架内血栓的单中心经验

doi:10.3969/j.issn.1673-5765.2021.06.005

摘要/Abstract

摘要： 目的探讨应用替罗非班治疗颅内动脉瘤支架辅助栓塞围手术期支架内血栓的有效性及安全性。方法回顾性分析2018年6月-2020年12月于华中科技大学同济医学院附属同济医院神经外科行支架辅助颅内动脉瘤栓塞术围手术期发生支架内血栓患者的临床资料，评估应用替罗非班对支架辅助颅内动脉瘤栓塞术围手术期血栓的治疗效果，包括血栓是否溶通、围手术期出血发生率及出院时 mRS评分。结果 177例接受支架辅助弹簧圈栓塞术的患者中，12例（6.8%）发生围手术期血栓事件，年龄中位数56.5岁，女性11例（91.7%），均为未破裂动脉瘤。前循环动脉瘤10例（83.3%），后循环动脉瘤2 例（16.7%）。4例（33.3%）选用了激光雕刻支架，8例（66.7%）选用了编织支架。术中发生血栓事件者9例（85.0%），术后发生血栓事件3例（15.0%）。应用替罗非班后，12例支架内血栓均成功溶通，其中1例发生颅内出血事件，出院时预后不良（mRS 4分）；其余11例（91.7%）均无相关并发症，预后良好（均mRS 0分）。结论支架辅助弹簧圈栓塞颅内动脉瘤围手术期出现支架内血栓时，应用替罗非班是一种安全、有效的治疗方法。

文章导读： 替罗非班治疗支架辅助弹簧圈栓塞颅内动脉瘤围手术期支架内血栓形成安全有效。

关键词: 替罗非班; 颅内动脉瘤; 支架辅助栓塞; 血栓形成; 围手术期

Abstract: Objective To investigate the efficacy and safety of tirofiban in treatment of periprocedural in-stent thrombosis during stent-assisted coiling of intracranial aneurysms. Methods This retrospective analysis enrolled the patients with perioprocedural in-stent thrombosis during stent-assisted coiling for intracranial aneurysms at Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology from June 2018 to December 2020. The clinical data of all the patients were analyzed to evaluate the efficacy and safety of tirofiban for periprocedural thrombosis, and the assessment indexes included the thrombus dissolution rate, periprocedural bleeding and mRS score at discharge. Results Of 177 patients who underwent stent-assisted coil embolization, 12 cases (6.8%) had periprocedural thrombotic events, with a median age of 56.5 years and 11 (91.7%) females, including 10 cases (83.3%) with anterior circulation aneurysms and 2 cases (16.7%) with posterior circulation aneurysms, all of which were unruptured aneurysms. Laser sculpting stents were used in 4 cases (33.3%) and braided stents were used in 8 cases (66.7%). Intraprocedural thrombotic events occurred in 9 cases (85.0%), and postprocedural thrombotic events occurred in 3 cases (15.0%). After the application of tirofiban, the thrombus was successfully dissolved in all 12 patients. Only one patient had an intracerebral hemorrhage after using tirofiban, and this patient had a poor prognosis (mRS 4 points) at discharge, and the remaining 11 patients (91.7%) had no complication and they all had a good prognosis (all mRS 0 point). Conclusions The application of tirofiban is a safe and effective treatment for periprocedural instent thrombosis during stent-assisted coiling of intracranial aneurysms.

Key words: Tirofiban; Intracranial aneurysm; Stent-assisted embolization; Thrombosis;Periprocedural

徐伟东, 陈如东, 厉华, 曾令成, 杨洪宽, 于加省. 替罗非班治疗颅内动脉瘤介入围手术期支架内血栓的单中心经验[J]. 中国卒中杂志, 2021, 16(06): 556-560.

XU Wei-Dong, CHEN Ru-Dong, LI Hua, ZENG Ling-Cheng, YANG Hong-Kuan, YU Jia-Sheng. Tirofiban for Periprocedural In-stent Thrombosis during Stent-assisted Coiling of Intracranial Aneurysms:A Single Center Experience#br#[J]. Chinese Journal of Stroke, 2021, 16(06): 556-560.

参考文献

[1] 中国卒中学会，中国卒中学会神经介入分会，中华预
防医学会卒中预防与控制专业委员会介入学组. 替罗
非班在动脉粥样硬化性脑血管疾病中的临床应用专
家共识[J]. 中国卒中杂志，2019，14（10）：1034-1044.
[2] 魏社鹏，赵继宗. 未破裂颅内动脉瘤的研究进展[J].
国际神经病学神经外科学杂志，2017，44（3）：311-
315.
[3] 牟汝涛，刘一之，倪才方，等. 替罗非班在支架辅助
颅内动脉瘤栓塞中的安全性及有效性[J]. 中国介入
影像与治疗学，2017，14（3）：129-133.
[4] MINE B，ALJISHI A，D'HARCOUR J B，et al.
Stent-assisted coiling of unruptured intracranial
aneurysms：long-term follow-up in 164 patients with
183 aneurysms[J]. J Neuroradiol，2014，41（5）：322-
328.
[5] BRINJIKJI W，MORALES-VALERO S F，MURAD
M H，et al. Rescue treatment of thromboembolic
complications during endovascular treatment of
cerebral aneurysms：a meta-analysis[J]. AJNR，2015，
36（1）：121-125.
[6] PIEROT L，COGNARD C，ANXIONNAT R，et al.
Ruptured intracranial aneurysms：factors affecting
the rate and outcome of endovascular treatment
complications in a series of 782 patients（CLARITY
study）[J]. Radiology，2010，256（3）：916-923.
[7] LIU A H，PENG T M，QIAN Z H，et al.
Enterprise stent-assisted coiling for wide-necked
intracranial aneurysms during ultra-early（48
hours）subarachnoid hemorrhage：a singlecenter
experience in 59 consecutive patients[J]. J
Neuroradiol，2015，42（5）：298-303.
[8] YANG H C，SUN Y，JIANG Y H，et al. Comparison
of stent-assisted coiling vs coiling alone in 563
intracranial aneurysms：safety and efficacy at a highvolume
center[J]. Neurosurgery，2015，77（2）：241-
247.
[9] 金二亮，祝源，杨李，等. 替罗非班在颅内动脉瘤支
架辅助栓塞术中抗血小板聚集的临床研究[J]. 中华
神经外科杂志，2017，33（4）：349-353.
[10] KIM S H，KIM T G，KONG M H. Intra-arterial and
intravenous tirofiban infusion for thromboembolism
during endovascular coil embolization of cerebral
aneurysm[J]. J Korean Neurosurg Soc，2017，60（5）：
518-526.
[11] JEON J S，SHEEN S H，HWANG G，et
al. Intraarterial tirofiban thrombolysis for
thromboembolisms during coil embolization for
ruptured intracranial aneurysms[J]. J Cerebrovasc
Endovasc Neurosurg，2012，14（1）：5-10.

[1]	王李, 李振水, 吴俊, 许英霞, 郝春满. 接受围手术期标准加速康复管理的颅内动脉瘤患者营养状态与显微外科夹闭术后并发症关系研究[J]. 中国卒中杂志, 2022, 17(09): 966-971.
[2]	康帅, 韩鹤泽, 鲁峻麟, 陈晓霖, 陈玉, 叶迅, 王嵘, 赵元立. 烟雾病血运重建术后非感染性发热的发病率与危险因素分析[J]. 中国卒中杂志, 2022, 17(07): 742-747.
[3]	宋新杰, 王安心, 李子孝, 赵性泉. 下肢深静脉血栓形成与脑出血患者预后的关系研究[J]. 中国卒中杂志, 2022, 17(06): 634-637.
[4]	张俊良, 黄双凤, 徐璐瑶, 向薇, 张曼曼, 梁志刚. 替罗非班治疗MRI筛选的轻中度非心源性缺血性卒中的安全性和有效性研究[J]. 中国卒中杂志, 2022, 17(01): 66-72.
[5]	薛晶, 张广, 孙宏巍, 翟蕴, 孙艳艳, 汤颖. 以细菌性脑膜炎为病因的合并脑小血管病影像表现的颅内深静脉血栓形成1例[J]. 中国卒中杂志, 2021, 16(12): 1273-1277.
[6]	鲁悦, 陶涛, 庄宗, 李伟, 杭春华. 以问题为基础教学法在颅内动脉瘤外科治疗临床教学中的应用[J]. 中国卒中杂志, 2021, 16(12): 1302-1304.
[7]	齐迎春, 陈雯, 程芮. 非心脏手术围手术期卒中危险因素的研究进展[J]. 中国卒中杂志, 2021, 16(11): 1189-1193.
[8]	曹毅. 支架辅助栓塞在颅内动脉瘤治疗中的应用[J]. 中国卒中杂志, 2021, 16(06): 533-536.
[9]	胡航, 曹毅, 鲍娟. 血流导向装置治疗颅内大型或巨大型动脉瘤的研究进展[J]. 中国卒中杂志, 2021, 16(06): 538-543.
[10]	何宜轩, 王冰, 邓剑平, 于嘉, 赵振伟. 血管内治疗床突旁未破裂颅内动脉瘤的疗效分析[J]. 中国卒中杂志, 2021, 16(06): 551-555.
[11]	王小雅，吴宇伦，坚雅婷，李涛，赵莉莉，陆家梁，路子微，党美娟，李也，张益恒，王何莹，张磊，张桂莲. 1例颅内动脉支架内亚急性血栓反复形成的思考[J]. 中国卒中杂志, 2021, 16(05): 516-519.
[12]	许莉，袁丹，巩忠，王英鹏，李冬华，王海鹏. 以头痛为唯一临床表现的脑静脉窦血栓形成患者的头痛特征[J]. 中国卒中杂志, 2020, 15(12): 1313-1316.
[13]	刘亚玲，于秋红，王丛，薛连璧. 高压氧治疗未破裂颅内动脉瘤夹闭术后脑梗死疗效及影响因素分析[J]. 中国卒中杂志, 2020, 15(08): 842-847.
[14]	中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 替罗非班在动脉粥样硬化性脑血管疾病中的临床应用专家共识[J]. 中国卒中杂志, 2019, 14(10): 1034-1044.
[15]	李矜玥, 于美玉, 焦卓敏, 张雪梅. 合并脑梗死的肥厚性硬脑膜炎1例[J]. 中国卒中杂志, 2019, 14(09): 926-932.